About the 3D Bioprinting Cancer Session
3D Bioprinting in Cancer, The landscape of cancer research is witnessing a revolutionary stride forward with the integration of 3D bioprinting technology. This innovative approach allows scientists to recreate intricate tumour microenvironments, providing a more realistic platform for studying cancer progression and response to treatments. 3D Bioprinting in Cancer enables the precise arrangement of cancer cells, stromal cells, and supporting structures, offering researchers unparalleled insights into the complexities of tumour biology. Beyond its utility as a research tool, 3D bioprinting holds promise in personalized medicine, as it can be used to develop patient-specific cancer models for testing potential therapies. This transformative technology stands at the forefront of efforts to understand and combat cancer, offering new avenues for targeted treatments and paving the way for more effective strategies in the fight against this formidable disease.
Topics Covered in 3D Bioprinting Cancer
Tumor Microenvironment Modeling
Bioink Development for Tumor Models
Vascularized Tumor Constructs
Drug Screening Platforms
Patient-Derived Cancer Models
Related Scientific Sessions at Materials 2027
Why Attend the 3D Bioprinting Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original 3D Bioprinting Cancer work, reviewed by the scientific committee.
Network Globally
Meet materials researchers, engineers, and academics from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping 3D Bioprinting Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join Materials 2027 for the 3D Bioprinting Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
3D Bioprinting Cancer Conference 2027 — FAQs
What is the 3D Bioprinting Cancer track at Materials 2027?
The 3D Bioprinting Cancer track is a dedicated stream within Materials 2027 covering the latest research, methods, and applications in 3D Bioprinting Cancer. It brings together researchers, engineers, and academics for oral presentations, posters, and discussion.
Who should attend the 3D Bioprinting Cancer sessions?
Materials researchers, engineers, educators, doctoral students, and R&D leaders with an interest in 3D Bioprinting Cancer are all welcome — whether presenting or attending.
Can I present my research in the 3D Bioprinting Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for 3D Bioprinting Cancer sessions?
Yes. Materials 2027 is a hybrid conference — attend the 3D Bioprinting Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the Materials 2027 delegation
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.